Page last updated: 2024-11-08

diethylnitrosamine and Fibrosis

diethylnitrosamine has been researched along with Fibrosis in 17 studies

Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to investigate the effect of combined therapy of diacerein and gold nanoparticles (AuNP) on diethylnitrosamine (DEN) induced hepatocellular carcinoma (HCC) in a rat model."8.31Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study. ( Baokbah, TAS, 2023)
"These findings demonstrated that ADSC-derived exosomes could efficiently alleviate hepatic fibrosis by suppressing HSCs activation and remodeling glutamine and ammonia metabolism mediated by hepatocellular glutamine synthetase, which might be a novel and promising anti-fibrotic therapeutics for hepatic fibrosis disease."8.12ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. ( Feng, J; Fu, Q; Guo, J; Ling, B; Ning, K; Wang, J; Wu, B; Xiu, G; Xu, J, 2022)
"To test the hypotheses that (i) heavier rats demonstrate improved survival with diminished fibrosis in a diethylnitrosamine (DEN)-induced model of hepatocellular carcinoma (HCC) and (ii) transarterial embolization via femoral artery access decreases procedure times versus carotid access."7.85Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization. ( Furth, EE; Gade, TP; Hunt, SJ; Kiefer, RM; Nadolski, GJ; Pickup, S; Pulido, S; Soulen, MC, 2017)
"The Diethylnitrosamine (DEN) model has an age-related effect."5.56A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma. ( Jung, Y; Lee, JI; Lee, WK; Memon, A; Pyao, Y, 2020)
" Thus, we hypothesized that chronic administration of different DEN treatments identifies the best-fit dose to induce the HCC and/or to determine whether small DEN doses act synergistically with other known hepatotoxins to induce HCC in mice."5.51Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice. ( Alarcón-Sánchez, BR; Aparicio-Bautista, DI; Arellanes-Robledo, J; Baltiérrez-Hoyos, R; Castro-Gil, MP; Fuentes-Hernández, S; Guerrero-Escalera, D; Idelfonso-García, OG; Lakshman, MR; López-González, ML; Montes-Aparicio, AV; Pérez-Carreón, JI; Pérez-Hernández, JL; Reyes-Gordillo, K; Rosas-Madrigal, S; Sierra-Santoyo, A; Vásquez-Garzón, VR; Villa-Treviño, S, 2019)
"Our findings showed that in hepatocarcinogenesis by diethylnitrosamine, cellular senescence is associated with p16 pathway activation and is mainly localized in myofibroblast-like cells."5.43Double staining of β-galactosidase with fibrosis and cancer markers reveals the chronological appearance of senescence in liver carcinogenesis induced by diethylnitrosamine. ( Alemán-Lazarini, L; Arellanes-Robledo, J; Fattel-Fazenda, S; Pacheco-Rivera, R; Pérez-Carreón, J; Rodríguez-Segura, M; Serrano-Luna, J; Shibayama, M; Silva-Olivares, A; Villa-Treviño, S, 2016)
"Interestingly, HFD, which induced hyperlipidemia and hepatic steatosis, attenuated DEN-related malnutrition and fibrosis progression in HFD + DEN group during 10-14 weeks."5.40High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. ( Ding, WJ; Duan, XY; Fan, JG; Pan, Q; Qiao, L; Yan, SY, 2014)
"The purpose of this study was to investigate the effect of combined therapy of diacerein and gold nanoparticles (AuNP) on diethylnitrosamine (DEN) induced hepatocellular carcinoma (HCC) in a rat model."4.31Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study. ( Baokbah, TAS, 2023)
" O-GlcNAc transferase-KO mice exacerbated diethylnitrosamine-induced HCC development with increased inflammation, fibrosis, and YAP signaling."4.31The essential role of O-GlcNAcylation in hepatic differentiation. ( Apte, U; Hanover, JA; Kotulkar, M; Paine-Cabrera, D; Robarts, DR; Slawson, C; Venneman, KK; Zachara, NE, 2023)
"These findings demonstrated that ADSC-derived exosomes could efficiently alleviate hepatic fibrosis by suppressing HSCs activation and remodeling glutamine and ammonia metabolism mediated by hepatocellular glutamine synthetase, which might be a novel and promising anti-fibrotic therapeutics for hepatic fibrosis disease."4.12ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis. ( Feng, J; Fu, Q; Guo, J; Ling, B; Ning, K; Wang, J; Wu, B; Xiu, G; Xu, J, 2022)
"To test the hypotheses that (i) heavier rats demonstrate improved survival with diminished fibrosis in a diethylnitrosamine (DEN)-induced model of hepatocellular carcinoma (HCC) and (ii) transarterial embolization via femoral artery access decreases procedure times versus carotid access."3.85Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization. ( Furth, EE; Gade, TP; Hunt, SJ; Kiefer, RM; Nadolski, GJ; Pickup, S; Pulido, S; Soulen, MC, 2017)
"The Diethylnitrosamine (DEN) model has an age-related effect."1.56A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma. ( Jung, Y; Lee, JI; Lee, WK; Memon, A; Pyao, Y, 2020)
" Thus, we hypothesized that chronic administration of different DEN treatments identifies the best-fit dose to induce the HCC and/or to determine whether small DEN doses act synergistically with other known hepatotoxins to induce HCC in mice."1.51Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice. ( Alarcón-Sánchez, BR; Aparicio-Bautista, DI; Arellanes-Robledo, J; Baltiérrez-Hoyos, R; Castro-Gil, MP; Fuentes-Hernández, S; Guerrero-Escalera, D; Idelfonso-García, OG; Lakshman, MR; López-González, ML; Montes-Aparicio, AV; Pérez-Carreón, JI; Pérez-Hernández, JL; Reyes-Gordillo, K; Rosas-Madrigal, S; Sierra-Santoyo, A; Vásquez-Garzón, VR; Villa-Treviño, S, 2019)
"Our findings showed that in hepatocarcinogenesis by diethylnitrosamine, cellular senescence is associated with p16 pathway activation and is mainly localized in myofibroblast-like cells."1.43Double staining of β-galactosidase with fibrosis and cancer markers reveals the chronological appearance of senescence in liver carcinogenesis induced by diethylnitrosamine. ( Alemán-Lazarini, L; Arellanes-Robledo, J; Fattel-Fazenda, S; Pacheco-Rivera, R; Pérez-Carreón, J; Rodríguez-Segura, M; Serrano-Luna, J; Shibayama, M; Silva-Olivares, A; Villa-Treviño, S, 2016)
"Many animal models of nonalcoholic steatohepatitis have been reported."1.43A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis. ( Ejima, C; Ishizaki, S; Kuroda, H, 2016)
"Interestingly, HFD, which induced hyperlipidemia and hepatic steatosis, attenuated DEN-related malnutrition and fibrosis progression in HFD + DEN group during 10-14 weeks."1.40High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. ( Ding, WJ; Duan, XY; Fan, JG; Pan, Q; Qiao, L; Yan, SY, 2014)
"Cirrhosis was induced in male Wistar rats by intraperitoneal administration of diethyl nitrosamine (DEN)."1.35Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis. ( Bozova, S; Elpek, GO; Gokhan, GA, 2008)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19902 (11.76)18.7374
1990's0 (0.00)18.2507
2000's3 (17.65)29.6817
2010's7 (41.18)24.3611
2020's5 (29.41)2.80

Authors

AuthorsStudies
Ghufran, H1
Azam, M1
Mehmood, A1
Butt, H1
Riazuddin, S1
Wu, B1
Feng, J1
Guo, J1
Wang, J1
Xiu, G1
Xu, J2
Ning, K1
Ling, B1
Fu, Q1
Baokbah, TAS1
Robarts, DR1
Kotulkar, M1
Paine-Cabrera, D1
Venneman, KK1
Hanover, JA1
Zachara, NE1
Slawson, C1
Apte, U1
Memon, A1
Pyao, Y1
Jung, Y1
Lee, JI1
Lee, WK1
Kiefer, RM1
Hunt, SJ1
Pulido, S1
Pickup, S1
Furth, EE1
Soulen, MC1
Nadolski, GJ1
Gade, TP1
Fuentes-Hernández, S1
Alarcón-Sánchez, BR1
Guerrero-Escalera, D1
Montes-Aparicio, AV1
Castro-Gil, MP1
Idelfonso-García, OG1
Rosas-Madrigal, S1
Aparicio-Bautista, DI1
Pérez-Hernández, JL1
Reyes-Gordillo, K1
Lakshman, MR1
Vásquez-Garzón, VR1
Baltiérrez-Hoyos, R1
López-González, ML1
Sierra-Santoyo, A1
Villa-Treviño, S2
Pérez-Carreón, JI1
Arellanes-Robledo, J2
Yi, X1
Long, L1
Yang, C1
Lu, Y1
Cheng, M1
Duan, XY1
Pan, Q1
Yan, SY1
Ding, WJ1
Fan, JG1
Qiao, L1
Pacheco-Rivera, R1
Fattel-Fazenda, S1
Silva-Olivares, A1
Alemán-Lazarini, L1
Rodríguez-Segura, M1
Pérez-Carreón, J1
Shibayama, M1
Serrano-Luna, J1
Ejima, C1
Kuroda, H1
Ishizaki, S1
Borbath, I1
Leclercq, IA1
Sempoux, C1
Abarca-Quinones, J1
Desaeger, C1
Horsmans, Y1
Bychkov, VG1
Trukhanova, LS1
Krylov, GG1
Kulikova, LN1
Mal'tseva, ED1
Smirnova, EA1
Kondalenko, VF1
Elpek, GO1
Gokhan, GA1
Bozova, S1
Corpechot, C1
Barbu, V1
Wendum, D1
Kinnman, N1
Rey, C1
Poupon, R1
Housset, C1
Rosmorduc, O1
Gans, JH1
Pintauro, SJ1
Couch, JA1
Courtney, LA1

Other Studies

17 other studies available for diethylnitrosamine and Fibrosis

ArticleYear
Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
    Experimental and molecular pathology, 2021, Volume: 123

    Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Diethylnitrosamin

2021
ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
    Stem cell research & therapy, 2022, 10-04, Volume: 13, Issue:1

    Topics: Ammonia; Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Diethylnitrosamine; Exosomes; Fib

2022
Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study.
    Journal of histotechnology, 2023, Volume: 46, Issue:1

    Topics: Animals; beta Catenin; Carcinoma, Hepatocellular; Caspase 3; Diethylnitrosamine; Fibrosis; Gold; Int

2023
The essential role of O-GlcNAcylation in hepatic differentiation.
    Hepatology communications, 2023, 11-01, Volume: 7, Issue:11

    Topics: Animals; Carcinoma, Hepatocellular; Cell Differentiation; Diethylnitrosamine; Fibrosis; Humans; Live

2023
A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
    International journal of molecular sciences, 2020, Jul-30, Volume: 21, Issue:15

    Topics: Animals; Carcinoma, Hepatocellular; Cell Proliferation; Diethylnitrosamine; Disease Models, Animal;

2020
Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization.
    Journal of vascular and interventional radiology : JVIR, 2017, Volume: 28, Issue:7

    Topics: Animals; Body Weight; Carcinoma, Hepatocellular; Diethylnitrosamine; Disease Models, Animal; Emboliz

2017
Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
    Toxicology and applied pharmacology, 2019, 09-01, Volume: 378

    Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Diethylnitrosamine; Drug Syn

2019
Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Alcoholic Beverages; Animals; Carcinoma, Hepatocellular; China; Diethylnitrosamine; Disease Models,

2014
High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    BMC gastroenterology, 2014, Nov-20, Volume: 14

    Topics: Animals; Apoptosis; Carcinogens; Carcinoma, Hepatocellular; Cell Proliferation; Diet, High-Fat; Diet

2014
Double staining of β-galactosidase with fibrosis and cancer markers reveals the chronological appearance of senescence in liver carcinogenesis induced by diethylnitrosamine.
    Toxicology letters, 2016, Jan-22, Volume: 241

    Topics: Animals; beta-Galactosidase; Biomarkers, Tumor; Carcinogenesis; Carcinogens; Cell Proliferation; Cel

2016
A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.
    Physiological reports, 2016, Volume: 4, Issue:21

    Topics: Animals; Cholesterol; Diet, High-Fat; Diethylnitrosamine; Disease Models, Animal; Fibrosis; Insulin

2016
Efficacy of lanreotide in preventing the occurrence of chemically induced hepatocellular carcinoma in rats.
    Chemico-biological interactions, 2010, Jan-05, Volume: 183, Issue:1

    Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Cell Proliferation; Diethylnitrosamine; Fibros

2010
[N-nitrosodiethylamine-induced changes in the liver of syrian hamster with superinvasive opistorchiasis].
    Voprosy onkologii, 2003, Volume: 49, Issue:4

    Topics: Animals; Carcinogens; Cricetinae; Diethylnitrosamine; Fibrosis; Liver; Liver Neoplasms, Experimental

2003
Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.
    World journal of gastroenterology, 2008, Apr-14, Volume: 14, Issue:14

    Topics: Animals; Antigens, CD34; Diethylnitrosamine; Disease Models, Animal; Fibrosis; Gene Expression Regul

2008
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.
    Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:5

    Topics: Alkylating Agents; Animals; Cells, Cultured; Collagen Type I; Collagen Type IV; Diethylnitrosamine;

2002
Liver scarring induced by polychlorinated biphenyl administration to mice previously treated with diethylnitrosamine.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1986, Volume: 183, Issue:2

    Topics: Animals; Aroclors; Body Weight; Chlorodiphenyl (54% Chlorine); Cicatrix; Diethylnitrosamine; Fibrosi

1986
N-nitrosodiethylamine-induced hepatocarcinogenesis in estuarine sheepshead minnow (Cyprinodon variegatus): neoplasms and related lesions compared with mammalian lesions.
    Journal of the National Cancer Institute, 1987, Volume: 79, Issue:2

    Topics: Animals; Bile Ducts; Cyprinidae; Diethylnitrosamine; Disease Models, Animal; Fibrosis; Fish Diseases

1987